·Î±×ÀÎ
ȸ¿ø°¡ÀÔ
±¤°í¹®ÀÇ
µ¶ÀÚÁ¦º¸
Event
´º½º
Àüü±â»ç
Á¤Ã¥ · ¹ý·ü
Á¦¾à · ¹ÙÀÌ¿À
¾à±¹ · º´¿ø
Ä«µå´º½º
ÆÊTV
À̽´¿µ»ó
DPÃÊ´ë¼®
À̽´Áø´Ü
¾Ë¾Æº¸Àâ
¿ÀÇǴϾð
Àü¹®°¡Ä®·³
µ¥½ºÅ©½Ã¼±
±âÀÚ¼öø
Ưº°±â°í
English
Policy
Opinion
Company
Product
Interview
TVÆÊµµ¶ó
ÆÊTube
ÆÊ¼îÇÎ
³ª´Â¾à»ç´Ù
ÆÊµå¶ó¸¶
ÆÊ¾ÆÄ«µ¥¹Ì
ÃʽÉŬ·¡½º
OTC»ó´ã
Á¦Ç°°ÁÂ
Çмú°ÁÂ
°æ¿µ°ÁÂ
Ä¿¹Â´ÏƼ
ÆÊ¸®Äí¸£Æ®
ä¿ëÁ¤º¸
PHARMARCY
ÀÎÀçÁ¤º¸
DPºÎµ¿»ê
¾à±¹ Q&A
¾à»ç´ëÃâ
¾à»ç½Å¿ë´ëÃâ
¼¼¹«»ó´ã
¼¼¹«·³ë¹«
¹ý·ü»ó´ã
¾à±¹°æ¿µ°úâ¾÷
ÀǾàÀÚ·á½Ç
ÀǾàÇàÁ¤
¾à»ç¾à±¹
ÀǷẴ¿ø
Á¦¾àÀ¯Åë
º¸µµÀÚ·á
ÆÊ½ºÅ¸Å¬·´
ÀÎ»ç · ºÎÀ½
¾à±¹ÀåÅÍ
ȸ»ç¼Ò°³
ȸ¿ø°¡ÀÔ
±¤°í¹®ÀÇ
»ç¾÷Á¦ÈÞ
ÀÎÅͳݽŹ®À±¸®°·É
µ¶ÀÚÁ¦º¸
±âÀÚÀ±¸®°·É
ÀÚÀ²¼¾à¼
¿ø°ÝÁö¿ø¿äû
Event & ¼¼¹Ì³ª
Àüü±â»ç
±×·¡ÇÈ
Á¤Ã¥¡¤¹ý·ü
Á¦¾à¡¤¹ÙÀÌ¿À
¾à±¹¡¤º´¿ø
±âȹ¡¤Å½»ç
Àü¹®°¡Ä®·³
µ¥½ºÅ©½Ã¼±
񃯇
񃯇
ÀǾàǰ
³¹¾Ë½Äº°
µ¥Àϸ®ÆÊ Live Search
´Ý±â
´º½º
>
Àüü ±â»ç
Àüü Çìµå¶óÀÎ ±â»ç
Àüü
|
08-14 (¸ñ)
|
08-13 (¼ö)
|
08-12 (È)
|
08-11 (¿ù)
|
08-10 (ÀÏ)
|
08-09 (Åä)
|
08-08 (±Ý)
º¹ÁöºÎ "ÇѾà»ç ¾à±¹¿¡ ÀǾàǰ °ø±Þ Á¦ÇÑ ÇÏÁö¸¶"
2025-08-11 12:10:20
[µ¥Àϸ®ÆÊ=°Çý°æ ±âÀÚ] ÇѾàÁ¦Á¦ Ãë±ÞÀ» ¹þ¾î³ ÇѾà»ç ¾÷¹«¹üÀ§¸¦ ³õ°í ¾à»ç´Üü ¹®Á¦Á¦±â°¡ À̾îÁö°í ÀÖ´Â °¡¿îµ¥, Á¤ºÎ´ç±¹ÀÌ Á¤´çÇÑ »çÀ¯ ¾ø´Â °ø±Þ °ÅÀýÀ» ±ÝÇÏ...
°Çý°æ ±âÀÚ
ÀÕµý Â÷·® µ¹Áø¿¡ ¾à±¹µé ºÒ¾È...¾ÈÀüÀåÄ¡ ¸¶·Ã ½Ã±Þ
2025-08-11 12:09:37
[µ¥Àϸ®ÆÊ=±èÁöÀº ±âÀÚ] Àü±¹ÀÇ Áö¿ª ¾à±¹À» Áß½ÉÀ¸·Î Â÷·® µ¹Áø »ç°í°¡ ÀÕµû¶ó ¹ß»ýÇÏ¸é¼ ¾à»çµéÀÇ ºÒ¾ÈÀÌ ³ô¾ÆÁö°í ÀÖ´Ù. ±â¹° ÆÄ¼ÕÀ» ³Ñ¾î Àθí ÇÇÇØ·Î±îÁö À̾î...
±èÁöÀº ±âÀÚ
"¾à°¡ÀÎÇÏ Á¦µµ ÅëÇÕ ½ÇÀÍ ¾ø¾î¡¦½Ã±â ÀÏ¿øÈ´Â È¿°úÀû"
2025-08-11 12:09:09
[µ¥Àϸ®ÆÊ=ÀÌÁ¤È¯ ±âÀÚ] ±¹³» ½ÃÆÇÁßÀÎ ½Å¾à¡¤Á¦³×¸¯¿¡ ´ëÇÑ »çÈİü¸®(¾à°¡ÀÎÇÏ) Á¦µµ¸¦ ÅëÇÕÇßÀ» ¶§ ±â´ëÇÒ ¼ö ÀÖ´Â ±¹¹Î ÆíÀÍÀ̳ª ±â´ë È¿°ú°¡ ¶³¾îÁ® ÅëÇÕ Çʿ伺...
ÀÌÁ¤È¯ ±âÀÚ
¹ÙÀÌ¿ÀÀǾàǰ ¹Ì ¼öÃâ¾× 8500¾ï¡¦°ü¼¼ Ÿ°Ý ºÒ°¡ÇÇ
2025-08-11 12:08:01
[µ¥Àϸ®ÆÊ=Â÷ÁöÇö ±âÀÚ] Áö³ÇØ ±¹»ê ¹ÙÀÌ¿ÀÀǾàǰÀÇ ¹Ì±¹ ¼öÃâ¾×ÀÌ Àü³â ´ëºñ 2¹è ÀÌ»ó Áõ°¡Çß´Ù. ¹Ì±¹ Æ®·³ÇÁ 2±â ÇàÁ¤ºÎÀÇ ÀǾàǰ °ü¼¼°¡ Çö½ÇÈÈ¸é ±¹³» ¹ÙÀÌ¿ÀÀÇ...
Â÷ÁöÇö ±âÀÚ
'5³â ÀûÀÚ 279¾ï' Çѱ¹ÄÚ·¯½º, °á±¹ ȸ»ýÀýÂ÷ ½Åû
2025-08-11 12:05:51
[µ¥Àϸ®ÆÊ=±èÁø±¸ ±âÀÚ] °æ¿µ³À¸·Î ´çÁ°ŷ¡°¡ Á¤ÁöµÈ Çѱ¹ÄÚ·¯½º°¡ °á±¹ ¹ý¿ø¿¡ ȸ»ýÀýÂ÷¸¦ ½ÅûÇß´Ù. ÀÌ È¸»ç´Â ÃÖ±Ù 5³â°£ °æ¿µ³ÀÌ ½ÉÈµÈ ¹Ù ÀÖ´Ù. 2020³âºÎÅÍ ...
±èÁø±¸ ±âÀÚ
¾Æº¸´ÙÆ®¡¤µà¿À´ÙÆ® ¼ö±Þ³¡¦ÇÑ ´Þ ÀÌ»ó ǰÀý ¿¹»ó
2025-08-11 12:04:48
[µ¥Àϸ®ÆÊ=°Çý°æ ±âÀÚ] Àü¸³¼± ºñ´ëÁõ°ú Å»¸ð Ä¡·á¿¡ ÁַΠó¹æµÇ´Â ¾Æº¸´ÙÆ®(µÎŸ½ºÅ׸®µå), µà¿À´ÙÆ®(µÎŸ½ºÅ׸®µå+޽º·Î½Å)¿¡¼ ǰÀýÀÌ ºú¾îÁ³´Ù. Áö³ ÁÖ ¾Æº¸...
°Çý°æ ±âÀÚ
¹Ì±¹, »ý¹°º¸¾È¹ý ÀÔ¹ý ¼Óµµ¡¦K-¹ÙÀÌ¿À ¹Ý»çÀÌÀÍ ±â´ë
2025-08-11 12:03:37
[µ¥Àϸ®ÆÊ=±èÁø±¸ ±âÀÚ] ¹Ì±¹ ÀÇȸ°¡ Áö³ÇØ ¹«»êµÈ ¡®»ý¹°º¸¾È¹ý¾È¡¯ÀÇ Ã³¸®¸¦ ÀçÃßÁøÇÑ´Ù. ÀÌ ¹ý¾ÈÀº ¿ì·Á ¹ÙÀÌ¿À±â¾÷(biotechnology companies of concern);À¸·Î ...
±èÁø±¸ ±âÀÚ
30³â Èí¿¬ÀÚ ¼Ò¼¼Æ÷Æó¾Ï ¹ß»ý À§Çè, ºñÈí¿¬ÀÚº¸´Ù 54.5¹è¡è
2025-08-11 12:00:39
[µ¥Àϸ®ÆÊ=ÀÌŹ¼ø ±âÀÚ] 30³â Èí¿¬ÀÚÀÇ ¼Ò¼¼Æ÷Æó¾Ï ¹ß»ý À§ÇèÀÌ ºñÈí¿¬ÀÚº¸´Ù 54.5¹è ³ôÀº °ÍÀ¸·Î ³ªÅ¸³µ´Ù. ±¹¹Î°Ç°º¸Çè°ø´Ü(ÀÌ»çÀå Á¤±â¼®) °Ç°º¸Ç迬±¸¿øÀº 11...
ÀÌŹ¼ø ±âÀÚ
SKÄɹÌÄ® Á¦¾à»ç¾÷ ¸ÅÃâ 58%¡è...'ÁøÅëÁ¦ °È È¿°ú'
2025-08-11 12:00:29
[µ¥Àϸ®ÆÊ=õ½ÂÇö ±âÀÚ] SKÄɹÌÄ®ÀÇ Á¦¾à»ç¾÷ ¸ÅÃâÀÌ ¼öÁ÷»ó½ÂÇß´Ù. ºñ¾ÆÆ®¸®½ºÀÇ ½Å¾à 3Á¾ÀÇ °øµ¿ ÆÇ¸Å¸¦ ½ÃÀÛÇÏ¸é¼ 1³â ¸¸¿¡ ¸ÅÃâÀÌ 50% ÀÌ»ó Áõ°¡ÇÏ¸ç ¿ª´ë ÃÖ´ë ±Ô...
õ½ÂÇö ±âÀÚ
³»³â 3¿ù ÅëÇÕµ¹º½¹ý ½ÃÇà...Á¤Àº°æ Àå°üÀÌ Á÷Á¢ ì±ä´Ù
2025-08-11 11:20:47
[µ¥Àϸ®ÆÊ=°½Å±¹ ±âÀÚ] ³»³â 3¿ù ÀÇ·á&8231;¿ä¾ç ÅëÇÕµ¹º½ »ç¾÷ ½ÃÇàÀ» ¾ÕµÎ°í Á¤ºÎ°¡ º»°ÝÀûÀÎ Áغñ¿¡ Âø¼öÇß´Ù. º¸°Çº¹ÁöºÎ(Àå°ü Á¤Àº°æ)´Â 11ÀÏ Á¦1Â÷ ÀÇ·á&8231...
°½Å±¹ ±âÀÚ
1
2
3
4
5
ä¿ë
¼Óº¸
ÁÖ¹®½Ã °áÁ¦±Ý¾×ÀÇ 5% Áï½Ã ÇÒÀÎ!
Çã´Ï¿¡¼¾½º ¸®À¯ÀúºíÄÅ ²Ü ¼±¹°¼¼Æ®
29%
34,300
¾ÆÀÌ¿ø Ŭ¸®³Ê¼¼Á¤ 20¸ÅÀÔ
12%
88,825¿ø
[¾¾¸®¾ó¸¶ÄÏ] ¹Ù»èÇÑ ¼ÓÃÊ ¸ÔÅÂ
46%
18,900
°üÀý¿£ ö°©»ó¾î&¼Ò¿¬°ñ Äܵå·ÎÀÌÄ£ ¹ÂÄÚ´Ù´ç´Ü¹é
26%
14,700
[Çϸ²] ¿ë°¡¸® ġŲ³Ê°Ù 1+1
38%
17,005¿ø
¹Ù¸£´Â ÆÄ½º Ä𸵠½ºÆ÷Ã÷°Ö
5%
9,500¿ø
¾ß»ý ºôº£¸®&¶óÁ¸® 6ÆÑ
25%
32,300¿ø
¹Ì¶óŬÅ彺 ¾îµå¹ê½ºµå ÆäÀÌ¼È Å¬·»Àú
50%
27,500
ºí·¢¾Þ°Å½º LA²É°¥ºñ ¼±¹°¼¼Æ®
79%
53,500
Å»¸ð¼¤Çª1À§¡Ú¸ðÅ彺¼¤Çª
44%
29,450¿ø
¿Ãµ¥ÀÌ KF94 ¸¶½ºÅ©
8%
250¿ø
[¶ó¿¤] À¯±â³ó ¼ø¸é »ý¸®´ë
34%
5,605¿ø
NEW ûÁ¤¿ø Á¤¼º12È£
37%
17,900
[»ïÇö] ¼Òµ¶¿ë¿¡Åº¿Ã
5%
760¿ø
[¿À¶óƽ½º] ±¸°À¯»ê±Õ 5°³¿ùºÐ
62%
85,500¿ø
ÄÚÄÚ½ºÅ丮 360 ¸¶±×³×½· ½ºÇÁ·¹ÀÌ
42%
7,000
[¿À¶óƽ½º] ÀÓÇöõƽ½º 5°³¿ùºÐ
61%
118,750¿ø
ÀÓ»êºÎ ¸®Æ÷ÆÛ ¾×»ó öºÐÁ¦
50%
15,000
µå¸²ÀÌÀ½ ¾ËÆÄ½ÃŬ·Î µ¦½ºÆ®¸° ´ÙÀÌ·ºÆ® ¾ËÆÄ
35%
11,000
¹Ì¶óŬÅ彺 ¾îµå¹ê½ºµå ¸®ÇÁÆÃ ¾ÚÇÃ
50%
44,000
[Á¤°üÀå] Àå»ý±âº¸ 30Æ÷
50%
149,000
µ¿¿øÂüÄ¡ Á¾ÇÕ A1È£
30%
17,500
[¸ÅÁ÷½¦ÇÁ] ¹Ì´Ï Á¦½À±â
37%
35,625
µ¿¿ø °Ç°ÇÑÂüÄ¡ ¼±¹°¼¼Æ®
30%
35,500
¾Ë¸² ¡¤ °øÇ¥
±³À° ¡¤ °ÁÂ
¾à±¹ Q&A
Á¢¼ö ¡¤ ¹®ÀÇ
¾Ë¸²
[µ¿¾ÆÁ¦¾à]Å»¸ð»ó´ãÀÇ ÇØ´ä, Ä«ÇÊ·¯½º À̺¥Æ® GO¢º
¾Ë¸²
ÆÊ½ºÅ¸Å¬·´ ·ê·¿ÄíÆù ¡æ ÆÊÆ÷ÀÎÆ® ±³È¯ À̺¥Æ® GO ¢º
¾Ë¸²
½Å°³³ä »êÁ¦Çü ¸Ö¹Ì¾à, ½ºÅä¸Ö»ê! POP & ¹æ¹®½Åû ¢º
¾Ë¸²
ÁøÅëÁ¦ ½À°ü Àâ´Â ±â¼ú! ʼ¾ »ó´ã °¡ÀÌµå ¹Þ±â ¢º
°øÇ¥
JW½Å¾à ÀǾàǰ(ÆÄ³ª´ýÅ©¸²) ȸ¼ö¿¡ °üÇÑ °øÇ¥
°øÇ¥
(ÁÖ)ÆÊÁ¨»çÀ̾𽺠ÀǾàǰ ȸ¼ö¿¡ °üÇÑ °øÇ¥
°øÇ¥
JW½Å¾à ÀǾàǰ(³ª¹«Á¹Á¤) ȸ¼ö¿¡ °üÇÑ °øÇ¥
D-112
ij³ª´Ù¾à»ç ½ÃÇè, ÀÌ·¸°Ô ¹Ù²ï´Ù! ( ~12.31 )
D-112
¾à¾÷°è ´ëÇ¥ ±³À°»çÀÌÆ®, ÆÊŬ·¡½º ( ~12.31 )
D-0
Áö¸£ÅØ Ä¡·á °¡À̵å¶óÀÎ ¢º »çÀüµî·Ï ( ~9.10 )
D-6
SGLT ¾ïÁ¦Á¦ ÇÙ½É º¹¾àÁöµµ ¢º»çÀü½Åû ( ~9.16 )
D-9
PV ¾÷¹«¿ª·® °È±³À° ¼ö°½Åû ¢º ( ~9.19 )
D-16
ÈѽºÅ»·Î Àд ¼ÒÈÁ¦ Æ®·»µå µî·Ï¢º ( ~9.26 )
¼¼¹«¡¤³ë¹«
(±Ù¹«¾à»ç ÁßµµÅð»ç) Ãß°¡ Áú¹®µå¸³´Ï´Ù
¾à±¹´ëÃâ
¾à±¹¿î¿µÀÚ±Ý
¾à±¹°æ¿µ°ú â¾÷
¾à±¹Ã¢¾÷°ü·Ã
ÀÚ»ê°ü¸®
Á¾½Åº¸Çè °è¾àÀÚ¿Ü ¼öÀÍÀÚ º¯°æ °¡´ÉÇѰ¡¿ä?
¹ý·ü»ó´ã
¸éÇã´ë¿©¾à±¹¿¡´ëÇÑ Áú¹®
¼¼¹«»ó´ã
±Ç¸®±ÝÀ» ³ª´²¼ ½Å°í ÇÒ ¼ö µµ ÀÖ³ª¿ä?
±³À° °Á ¹× ¾Ë¸² ±¤°í ¾È³» ÆäÀÌÁö
¿¬¼ö, ±³À°, ¼¼¹Ì³ª, Çмú°Á ¹× ±â¾÷±³À°, ¸ðÁý
°øÇ¥, Åä·Ðȸ, ÀǾàǰ º¯°æ ¾È³» ¹× °¢Á¾ Çà»ç
¾Ë¸² ±¤°í¸¦ ÇØµå¸³´Ï´Ù.
(Á¢¼ö ¹®ÀÇ ¹Ù·Î°¡±â)
¿À´ÃÀÇ
ÇÖ´º½º
1
ÇѾà»ç °³¼³ 250Æò ´ëÇü¾à±¹ °¡º¸´Ï...Àü·«Àº ¹Ú¸®´Ù¸Å
2
Äݸ° ÀÓ»ó ½ÇÆÐ?...ÃßÁ¤ ȯ¼ö¾× ºÎä ÀÎ½Ä Àü¹æÀ§ È®»ê
3
ÀÌ´Þ Áö±ÞµÇ´Â 2Â÷ ¼ÒºñÄíÆù ¸ø ¹Þ´Â ¾à»ç 10% ³ÑÀ» µí
4
Ȥ½Ã ¿ì¸®µµ?...Á¦¾à¾÷°è, ¹Ì±¹ Àη ±¸±Ý»çÅ ¿¹ÀÇÁÖ½Ã
5
[±âÀÚÀÇ ´«] 2¹è ´Ã¾î³ ¾à´ë ÀÚÅð»ý°ú â°íÇü¾à±¹
6
±¹Àü¾àǰ ÀÚȸ»ç, µ¿¾Æ¿¡½ºÆ¼¿Í Ç×¾ÏÁ¦ »ç¾÷ Á¦ÈÞ
7
±Ù·Î°è¾à¼ ¹Ì±³ºÎÇÑ ¾à±¹Àå, ±Ù·Î±âÁعý À§¹Ý 'µÈ¼¸®'
8
½ÃÆÇ ÈÄ ¾ÈÀü°ü¸® RMP ÀÏ¿øÈ...¼ººÐ °°À¸¸é ÅëÇÕ °ü¸® °¡´É
9
¾à»çȸ, ´ëüÁ¶Á¦ °£¼ÒÈ¡¤¼ººÐ¸í ó¹æ °ø·ÐÈ ½Ãµ¿
10
»ç¸Á À§Çè¡é¡¤»ýÁ¸ ±â°£¡è¡¦Æó¾ÏÄ¡·áÁ¦ º´¿ë µ¥ÀÌÅÍ °æÀï